about
Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance ManagementOsteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implicationsHepatic osteodystrophyDisturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study.Low bone mineral density in chronic hepatitis B virus infection: A case-control study.Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.Hepatobiliary complications of inflammatory bowel disease.Bone disorders in children and adolescents with chronic HCV infection.Chronic liver inflammation: clinical implications beyond alcoholic liver disease.Treatment of bone loss in patients with chronic liver disease awaiting liver transplantationLiver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study.Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens.Disease networks. Uncovering disease-disease relationships through the incomplete interactomeHepatic osteodystrophy: An important matter for consideration in chronic liver disease.Minimal hepatic encephalopathy impairs quality of life.Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody.Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunctionNon-alcoholic fatty liver disease is associated with low bone mineral density in obese childrenPegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection.Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean menSerum γ-Glutamyl Transferase Is Inversely Associated with Bone Mineral Density Independently of Alcohol Consumption.Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2Fractures after antiretroviral initiation.Metabolic Bone Disease in Viral Cirrhosis: A Prospective StudyVitamin D status in gastrointestinal and liver disease.Clinical pearls in gastroenterology.Current and future treatments of autoimmune hepatitis.Nutritional status and liver transplantation.Treatment options for primary sclerosing cholangitis.Bone disorders in chronic liver diseases.Osteodystrophy in chronic liver diseases.Long-term outcome after liver transplantation.Vitamin D in chronic liver disease.Alcohol and bone.A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.Bone health and vitamin D status in alcoholic liver disease.Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys.
P2860
Q26744040-3CA3E08C-AD25-4F11-B8EA-DF761B779CACQ26824690-C3A3CD1A-C295-442A-948D-EA658A72E646Q27004571-08863335-3163-44D8-906F-BE8D8FF5666FQ33392749-BA07CF69-67EF-4A88-9EF6-ABC8B6BC9942Q33690431-B69BD426-6BCF-4990-8857-2EDFCDAFBA95Q33794374-567619BE-15E8-4CBE-837E-68F2FF331DD5Q33966083-DE91A29F-14A0-4899-B40E-91E72280AE00Q34230367-3CAB0B36-E04F-47BD-A454-D41323D20953Q34408850-A514EC69-BD79-4C4C-908D-A4F69C4DCBECQ34570115-461902A9-B635-48F2-817A-9393E5B15359Q34942815-815457F9-1FF4-4311-8A3E-DE90A69B2972Q34985947-28059C00-18F0-4E36-9FD6-DF73E6226FA1Q35024409-73627540-7894-4EC6-927E-791BF105CAB1Q35212798-BEBD58F9-E7E6-47E5-B588-8A627A9879AFQ35619320-98CF6625-C14C-4EB5-A38D-739A0D0E3452Q35635642-1C5F621A-7602-4CE0-AE43-D4EF3A271F4DQ35642834-C0E7AD1E-C130-4416-BB63-907C84772413Q35791650-3098FF30-A6A6-4832-9A02-4F2E6B4ADC59Q36053216-9ED0D959-974A-4B38-8490-253262DD7AFCQ36219486-A9751079-18EB-4A54-8C2B-CFA0A3409769Q36263107-3C3A0B60-DBB5-49A1-9A88-760BCEB840ABQ36327938-3A3ED9E6-7145-4DB8-BDC0-4968A5698598Q36538444-E1262DB1-C116-4D24-959A-B40524CCF995Q36717045-1AF7EE80-C00B-4EDD-B51F-3E88983F4B4EQ36745236-F3FD4EBE-103F-496D-B33C-5D747D5B5077Q36839748-B0124C0F-1C50-4DA8-875E-33E6FF959D0CQ36961986-DBDFB83A-94C3-4097-966D-DEDA55212C35Q37095126-D79A80E8-83C4-435C-B985-C24466ED4CD6Q37371939-E13F533A-C3F3-4797-903A-39F38060708AQ37503380-49DA6812-2D1D-4588-8160-0FD5A3668375Q37613643-81D54EF6-7C7B-4A39-B53A-A9740D20CD65Q37777156-8368A91C-5D67-4103-8C47-62CB90602450Q37811999-611A9F78-AFFD-4CD9-8253-24FDAEEF741BQ37975457-97B9D312-E1C1-4DED-87D9-BC49D1A8FD94Q38002368-47B84713-9D96-44DA-AA99-0088313EE262Q38080943-6D626117-FF78-4D97-95A0-6A7603860755Q38183285-2B2F6121-9B95-4FA7-B3C8-7017EC79BC38Q38584285-DEE97CE6-415F-46F4-B898-83CE226A8899Q38849637-E862E022-D8E2-4C25-A307-DBBADE895EFEQ38911526-4B59DA85-FB90-4C82-85E9-3DCFB965166B
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bone disorders in chronic liver disease.
@en
type
label
Bone disorders in chronic liver disease.
@en
prefLabel
Bone disorders in chronic liver disease.
@en
P356
P1433
P1476
Bone disorders in chronic liver disease.
@en
P2093
Jane Collier
P2860
P304
P356
10.1002/HEP.21852
P407
P577
2007-10-01T00:00:00Z